Enhancing Care & Outcomes for Patients During the First Postpartum Year
Launched by UNIVERSITY OF MARYLAND, BALTIMORE · Sep 23, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve care for women during the first year after giving birth, especially those at higher risk for health problems. Women who have experienced pregnancy-related high blood pressure or diabetes are at greater risk for serious health issues, including heart disease, after childbirth. The goal of the trial is to see if having obstetric care providers, like doctors who specialize in pregnancy, offer ongoing care throughout the entire year after delivery can help these women stay healthier.
To join the study, participants need to be at least 18 years old, currently pregnant, and planning to receive care at the University of Maryland Medical Center. They should also have a diagnosis of high blood pressure or diabetes related to their pregnancy and have Medicaid insurance. Participants can expect regular check-ins and personalized care to address their specific health needs during this critical time. This trial is important because it aims to change the way postpartum care is provided, moving away from just one visit six weeks after delivery to a more supportive and continuous approach throughout the year.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 or older
- • Pregnant individuals
- • Planning to deliver and continue postpartum care at the University of Maryland Medical Center
- • Diagnosis of HDP or diabetes (pre-gestational or gestational) before discharge from admission for delivery
- • Medicaid insurance coverage
- Exclusion Criteria:
- • Less than 18 years of age
- • Fetal demise
- • No diagnosis of HDP and/or diabetes (pre-gestational or gestational)
- • Non-Medicaid insurance coverage
About University Of Maryland, Baltimore
The University of Maryland, Baltimore (UMB) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, UMB leverages its extensive resources and expertise across various disciplines, including medicine, pharmacy, nursing, and social work, to contribute to groundbreaking discoveries and improve patient outcomes. Committed to ethical research practices and collaboration, UMB fosters an environment that promotes the translation of scientific knowledge into real-world applications, ultimately enhancing the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Jenifer Fahey, CNM, PhD
Principal Investigator
University of Maryland, Baltimore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported